Find Comparable Stocks for Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN - NMSLife Sciences
Pharmaceutical Preparations
Country
USA
Market Cap
$76.4B
Dividend Yield
1%
Beta
0.27 (No Correlation)
Trading Volume
866.3K (Low)
Momentum
Very Weak
Very Weak
Very Strong
Value vs. Growth
Deep Value
Value
Rapid Growth
Quality
Poor
Good
Excellent
Size
Micro
Large
Mega Cap
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors.
Valuation
Financials
Momentum
Analyst Ratings
Trailing P/E
17.92
Forward P/E
15.06
PEG Ratio
1.01
Price/Book
2.56
EV/EBITDA
12.94
EV/Revenue
4.85
Income Statement
Revenue (TTM)
$14.2B
Gross Profit (TTM)
$7.1B
EBITDA
$4.6B
Financial Ratios
Profit Margin
31%
Operating Margin (TTM)
27%
Gross Profit Margin
50%
EBITDA Margin
33%
ROE (TTM)
16%
ROA (TTM)
7%
Growth
Quarterly Revenue Growth (YoY)
10%
Quarterly Earnings Growth (YoY)
-21%
52-Week Range
$641.18
$1,209.65
50-Day Moving Average
$697.35
Price vs. 50-Day MA
0.16%
200-Day Moving Average
$922.36
Price vs. 200-Day MA
-24.28%
Analyst Ratings Distribution
Median Price Target
$923.06
Price to Target
76%
Toggle between similar stocks
and ETFs for comparison.
Loading comparable stocks ...